Tempest Therapeutics, Inc. TPST
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-10-04
Tempest Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Angel Matthew | CEO and President | 2026-03-24 | Buy | 231,482 | $2.16 |
| Angel Matthew | CEO and President | 2026-03-24 | Buy | 231,482 | $2.16 |
Source: SEC EDGAR filings · CIK 0001544227 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.